Thought Leadership
Thought-provoking insights from an executive search perspective on the latest biopharma news, market shifts, and industry milestones.
Longevity Research Momentum Picks Up in Biotech
Last week, biotech news hubs were ablaze with the unexpected departure of Hal Barron, GSK’s R&D chief. In August Barron will take the helm as CEO of Altos Labs, headquartered in San Francisco, Californa…
New Developments in the Microbiome Research Progress Therapeutic Potential. How Executive Search Can Help in an unpredictable field
New developments in the continually evolving field of microbiome research have risen out of young startup Wild Biotech, a company whose focus is…
Synthetic Biology Shaping the Future of the Life Sciences Industry: How Executive Search Can Prepare Now
Synthetic biology is a new area of research and development that applies engineering principles to biological processes. Synthetic biology enables…
Distinguishing Recruitment from Talent Management: Why the Latter is Necessary in Today’s Life Sciences Industry
Distinguishing Recruitment from Talent Management: Why the Latter is Necessary in Today’s Life Sciences Industry…
Setting Sights on Korea as a new Biotech Hub
Demographically, South Korea has been an appealing investment opportunity for pharma companies. It has a relatively large population of around 51 million people…
Next-Gen Gene Therapy Solutions Creating New Niches in Executive Search
Next-gen gene therapy solutions are burgeoning in biotech, creating new niches for life sciences executive search consultants to move into when it…
Growing China Biopharma Market Appealing to US Investors: Importance for Life Sciences Executive Search Consultants
The growing biopharmaceutical market in China has become increasingly appealing to international entrepreneurs and investors, with recent…
The Biotech Industry Has the Power to Revolutionize Healthcare.
Discussion in biotech often focuses on new therapeutics and technologies being developed that have the potential to cure cancer and rare genetic diseases…
Spotlight on Biotech Companies
The spotlight is on biotech companies pursuing in vivo gene editing as the way forward for next-gen gene therapies. With clinical data released in June…